KPIs & Operating Metrics(New)
Breakdown Of AssetsEmployee StatisticsFixed Assets, Net BreakdownGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome (Loss) Before Income TaxLicense Revenue By Category AnnualOpex As A % Of Total Revenue %OPEX SegregationProduct Revenue By CategoryProduct Revenue By Category AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Trx By Product
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Gross Profit (2016 - 2023)

TherapeuticsMD (TXMD) has disclosed Gross Profit for 13 consecutive years, with $502000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Gross Profit fell 99.27% year-over-year to $502000.0, compared with a TTM value of $1.3 million through Dec 2023, down 97.09%, and an annual FY2023 reading of $1.3 million, down 98.1% over the prior year.
  • Gross Profit was $502000.0 for Q4 2023 at TherapeuticsMD, up from -$53000.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $68.6 million in Q4 2022 and bottomed at -$53.0 million in Q4 2021.
  • Average Gross Profit over 5 years is $7.3 million, with a median of $9.5 million recorded in 2020.
  • The sharpest move saw Gross Profit soared 702.7% in 2019, then tumbled 411.83% in 2021.
  • Year by year, Gross Profit stood at $13.0 million in 2019, then soared by 30.52% to $17.0 million in 2020, then crashed by 411.83% to -$53.0 million in 2021, then soared by 229.37% to $68.6 million in 2022, then crashed by 99.27% to $502000.0 in 2023.
  • Business Quant data shows Gross Profit for TXMD at $502000.0 in Q4 2023, -$53000.0 in Q3 2023, and $437000.0 in Q2 2023.